Potential of immunotherapy for hepatocellular carcinoma (Q27687362)

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

19 November 2024

1 reference

Ekaterina Breous

1

1 reference

Robert Thimme

2

1 reference

language of work or name

1 reference

April 2011

0 references

9 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

21145836

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21145836

full work available at URL

19 November 2024

https://doi.org/10.1016/j.jhep.2010.10.013

online access status

open access

1 reference

Europe PubMed Central

PubMed publication ID

21145836

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21145836

https://api.elsevier.com/content/article/PII:S0168827810009669?httpAccept=text/xml

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

https://api.elsevier.com/content/article/PII:S0168827810009669?httpAccept=text/plain

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

19 November 2024

published in

Journal of Hepatology

1 reference

volume

54

1 reference

issue

4

1 reference

page(s)

830-4

1 reference

Hepatocellular carcinoma--epidemiological trends and risk factors

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Molecular targeted therapies in hepatocellular carcinoma

19 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

19 November 2024

Hepatocellular carcinoma

3

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Sorafenib in advanced hepatocellular carcinoma

19 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation

19 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

19 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein

19 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination

19 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein

19 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer

19 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Comprehensive analysis of the alpha-fetoprotein-specific CD8 T cell responses in patients with hepatocellular carcinoma.

19 November 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma

19 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma

19 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma

19 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

The spontaneous CD8 T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients

19 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Naturally acquired MAGE-A10- and SSX-2-specific CD8 T cell responses in patients with hepatocellular carcinoma.

19 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8 cells in patients with hepatocellular carcinoma

19 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma

19 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells

19 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

19 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

19 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4 T-cell responses in patients with advanced HCC

19 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4( )CD25( )Foxp3( ) T cells

19 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma

19 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma

19 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma

19 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Kupffer cell suppression of CD8 T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions

19 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

19 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

19 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8 T cell dysfunction in melanoma patients

19 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease

19 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four -Fetoprotein Peptides

19 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.

19 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

Activation of dendritic cells by local ablation of hepatocellular carcinoma

19 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.10.013

19 November 2024

Identifiers

0 references

PubMed publication ID

21145836

1 reference